Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Ruilope

Showing results (41-50 of 284) with videos related to

Pageof 29
Sort By:
International Journal of Clinical Practice|November 9, 2004
The case for blood pressure control in risk groupsL M Ruilope, M Volpe
Revista Espanola De Cardiologia|June 22, 1999
[New guidelines from the World Health Organization and the International Society of Hypertension for the management of hypertension: toward common guidelines]C Suárez, L M Ruilope
Medicina Clinica|July 28, 1999
[How much should arterial pressure figures be lowered with treatment? Reflections after the HOT (Hypertension Optimal Treatment) study]A Coca, L M Ruilope
Lancet (London, England)|July 7, 2009
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trialJ Segura, L M Ruilope
Medicina Clinica|April 29, 2000
[Arterial hypertension: the better we know it, the worse we treat it]C Suárez, L M Ruilope
Expert Opinion on Pharmacotherapy|October 12, 2012
Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertensionL M Ruilope, Helmut Schumacher
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
How far should blood pressure be reduced in diabetic hypertensive patients?L M Ruilope, R García-Robles
Current Hypertension Reports|May 17, 2001
Hyperuricemia and renal functionL M Ruilope, J Garcia-Puig
Blood Pressure. Supplement|January 1, 1996
Hypertension, atherosclerosis and microalbuminuria in ELSA. European Lacidipine Study of AtherosclerosisL M Ruilope, J L Rodicio
Hipertension Y Riesgo Vascular|June 18, 2018
[Mortality study from the Spanish Registry of ABPM. An appeal for the transition of ABPM to clinical practice]J R Banegas, L M Ruilope
Pageof 29

Showing results (41-50 of 284) with videos related to

Sort By:
Pageof 29
International Journal of Clinical Practice|November 9, 2004
The case for blood pressure control in risk groupsL M Ruilope, M Volpe
Revista Espanola De Cardiologia|June 22, 1999
[New guidelines from the World Health Organization and the International Society of Hypertension for the management of hypertension: toward common guidelines]C Suárez, L M Ruilope
Medicina Clinica|July 28, 1999
[How much should arterial pressure figures be lowered with treatment? Reflections after the HOT (Hypertension Optimal Treatment) study]A Coca, L M Ruilope
Lancet (London, England)|July 7, 2009
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trialJ Segura, L M Ruilope
Medicina Clinica|April 29, 2000
[Arterial hypertension: the better we know it, the worse we treat it]C Suárez, L M Ruilope
Expert Opinion on Pharmacotherapy|October 12, 2012
Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertensionL M Ruilope, Helmut Schumacher
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
How far should blood pressure be reduced in diabetic hypertensive patients?L M Ruilope, R García-Robles
Current Hypertension Reports|May 17, 2001
Hyperuricemia and renal functionL M Ruilope, J Garcia-Puig
Blood Pressure. Supplement|January 1, 1996
Hypertension, atherosclerosis and microalbuminuria in ELSA. European Lacidipine Study of AtherosclerosisL M Ruilope, J L Rodicio
Hipertension Y Riesgo Vascular|June 18, 2018
[Mortality study from the Spanish Registry of ABPM. An appeal for the transition of ABPM to clinical practice]J R Banegas, L M Ruilope
Pageof 29